452 related articles for article (PubMed ID: 34147519)
1. Interferon-Gamma-Producing CD8
Sasson SC; Slevin SM; Cheung VTF; Nassiri I; Olsson-Brown A; Fryer E; Ferreira RC; Trzupek D; Gupta T; Al-Hillawi L; Issaias ML; Easton A; Campo L; FitzPatrick MEB; Adams J; Chitnis M; Protheroe A; Tuthill M; Coupe N; Simmons A; Payne M; Middleton MR; Travis SPL; ; Fairfax BP; Klenerman P; Brain O
Gastroenterology; 2021 Oct; 161(4):1229-1244.e9. PubMed ID: 34147519
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis.
Thomas MF; Slowikowski K; Manakongtreecheep K; Sen P; Samanta N; Tantivit J; Nasrallah M; Zubiri L; Smith NP; Tirard A; Ramesh S; Arnold BY; Nieman LT; Chen JH; Eisenhaure T; Pelka K; Song Y; Xu KH; Jorgji V; Pinto CJ; Sharova T; Glasser R; Chan P; Sullivan RJ; Khalili H; Juric D; Boland GM; Dougan M; Hacohen N; Li B; Reynolds KL; Villani AC
Nat Med; 2024 May; 30(5):1349-1362. PubMed ID: 38724705
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.
Hone Lopez S; Kats-Ugurlu G; Renken RJ; Buikema HJ; de Groot MR; Visschedijk MC; Dijkstra G; Jalving M; de Haan JJ
Virchows Arch; 2021 Dec; 479(6):1119-1129. PubMed ID: 34338882
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.
Luoma AM; Suo S; Williams HL; Sharova T; Sullivan K; Manos M; Bowling P; Hodi FS; Rahma O; Sullivan RJ; Boland GM; Nowak JA; Dougan SK; Dougan M; Yuan GC; Wucherpfennig KW
Cell; 2020 Aug; 182(3):655-671.e22. PubMed ID: 32603654
[TBL] [Abstract][Full Text] [Related]
5. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
[TBL] [Abstract][Full Text] [Related]
6. Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis.
van Eijs MJM; Ter Linde JJM; Baars MJD; Amini M; Laclé MM; Brand EC; Delemarre EM; Drylewicz J; Nierkens S; Verheijden RJ; Oldenburg B; Vercoulen Y; Suijkerbuijk KPM; van Wijk F
iScience; 2023 Oct; 26(10):107891. PubMed ID: 37766980
[TBL] [Abstract][Full Text] [Related]
7. CXCR6 deficiency impairs cancer vaccine efficacy and CD8
Karaki S; Blanc C; Tran T; Galy-Fauroux I; Mougel A; Dransart E; Anson M; Tanchot C; Paolini L; Gruel N; Gibault L; Lepimpec-Barhes F; Fabre E; Benhamouda N; Badoual C; Damotte D; Donnadieu E; Kobold S; Mami-Chouaib F; Golub R; Johannes L; Tartour E
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692218
[TBL] [Abstract][Full Text] [Related]
8. Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Simonds EF; Lu ED; Badillo O; Karimi S; Liu EV; Tamaki W; Rancan C; Downey KM; Stultz J; Sinha M; McHenry LK; Nasholm NM; Chuntova P; Sundström A; Genoud V; Shahani SA; Wang LD; Brown CE; Walker PR; Swartling FJ; Fong L; Okada H; Weiss WA; Hellström M
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083417
[TBL] [Abstract][Full Text] [Related]
9. Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells.
Tilly G; Cadoux M; Garcia A; Morille J; Wiertlewski S; Pecqueur C; Brouard S; Laplaud D; Degauque N
Front Immunol; 2021; 12():730342. PubMed ID: 34721394
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis.
Grover S; Dougan M; Tyan K; Giobbie-Hurder A; Blum SM; Ishizuka J; Qazi T; Elias R; Vora KB; Ruan AB; Martin-Doyle W; Manos M; Eastman L; Davis M; Gargano M; Haq R; Buchbinder EI; Sullivan RJ; Ott PA; Hodi FS; Rahma OE
Cancer; 2020 Aug; 126(16):3758-3767. PubMed ID: 32567084
[TBL] [Abstract][Full Text] [Related]
11. ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis.
Mann JE; Lucca L; Austin MR; Merkin RD; Robert ME; Al Bawardy B; Raddassi K; Aizenbud L; Joshi NS; Hafler DA; Abraham C; Herold KC; Kluger HM
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586769
[TBL] [Abstract][Full Text] [Related]
12. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; He R; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
Circulation; 2024 Jan; 149(1):48-66. PubMed ID: 37746718
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials.
Mankor JM; Disselhorst MJ; Poncin M; Baas P; Aerts JGJV; Vroman H
EBioMedicine; 2020 Dec; 62():103040. PubMed ID: 33166791
[TBL] [Abstract][Full Text] [Related]
14. Differential risks of immune-related colitis among various immune checkpoint inhibitor regimens.
Yao J; Li M; Zhang H; Ge Y; Weygant N; An G
Int Immunopharmacol; 2020 Oct; 87():106770. PubMed ID: 32702598
[TBL] [Abstract][Full Text] [Related]
15. Tissue-Resident-Memory CD8
Peng T; Phasouk K; Sodroski CN; Sun S; Hwangbo Y; Layton ED; Jin L; Klock A; Diem K; Magaret AS; Jing L; Laing K; Li A; Huang ML; Mertens M; Johnston C; Jerome KR; Koelle DM; Wald A; Knipe DM; Corey L; Zhu J
Front Immunol; 2021; 12():735643. PubMed ID: 34552595
[TBL] [Abstract][Full Text] [Related]
16. Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses.
Santos PM; Adamik J; Howes TR; Du S; Vujanovic L; Warren S; Gambotto A; Kirkwood JM; Butterfield LH
J Exp Med; 2020 Jul; 217(7):. PubMed ID: 32369107
[TBL] [Abstract][Full Text] [Related]
17. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts.
Bortolomeazzi M; Keddar MR; Montorsi L; Acha-Sagredo A; Benedetti L; Temelkovski D; Choi S; Petrov N; Todd K; Wai P; Kohl J; Denner T; Nye E; Goldstone R; Ward S; Wilson GA; Al Bakir M; Swanton C; John S; Miles J; Larijani B; Kunene V; Fontana E; Arkenau HT; Parker PJ; Rodriguez-Justo M; Shiu KK; Spencer J; Ciccarelli FD
Gastroenterology; 2021 Oct; 161(4):1179-1193. PubMed ID: 34197832
[TBL] [Abstract][Full Text] [Related]
18. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
19. Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management.
Plunkett KR; Armitage JD; Inderjeeth AJ; McDonnell AM; Waithman J; Lau PKH
Front Immunol; 2022; 13():1048758. PubMed ID: 36466880
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines.
Reschke R; Shapiro JW; Yu J; Rouhani SJ; Olson DJ; Zha Y; Gajewski TF
Cancer Immunol Res; 2022 Oct; 10(10):1167-1174. PubMed ID: 35977003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
